Apotex's Planned Angiomax Generic Spurs Patent Suit
The Medicines Co. hit generic-drug maker Apotex Inc. with an infringement suit in New Jersey federal court on Tuesday, claiming the company's application to market a generic version of the blood...To view the full article, register now.
Already a subscriber? Click here to view full article